Jamie Phares, Managing Director, Janssen, the Pharmaceutical Companies of Johnson & Johnson in the GCC, comments on the evolving approach to healthcare provision in the region, the role of Saudi Arabia in the regional healthcare market, and what the country needs to further develop its biopharma sector. In addition, she explains why new types of reimbursement models, such as value-based initiatives, should be tailored to the current capabilities of the region’s healthcare systems, and why compassionate leadership is crucial to success as a life sciences executive.
Biopharmaceutical companies have a big role to play in advancing innovation for health and driving collaborations to deliver better healthcare outcomes.
